Aurinia Pharmaceuticals Inc. (AUPH)

6.31
0.01 0.16
NASDAQ
Prev Close 6.32
Open 6.32
Day Low/High 6.21 / 6.38
52 Wk Low/High 5.01 / 7.85
Volume 438.62K
Exchange NASDAQ
Shares Outstanding 91.64B
Market Cap 579.14M
Div & Yield N.A. (N.A)

Latest News

The Fed Decision Will Be a Market Mover No Matter What

The Fed Decision Will Be a Market Mover No Matter What

Computer algorithms will trigger volatility even if there is no surprise news.

Aurinia Reports Fourth Quarter And Full Year 2018 Financial Results And Operational Highlights

Aurinia Reports Fourth Quarter And Full Year 2018 Financial Results And Operational Highlights

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) ("Aurinia" or the "Company") today reported its financial results for the fourth quarter and year ended December 31, 2018.

Aurinia Recognizes World Kidney Day And National Kidney Month With New Activities Focused On Raising Awareness For Kidney Disease

Aurinia Recognizes World Kidney Day And National Kidney Month With New Activities Focused On Raising Awareness For Kidney Disease

In recognition of World Kidney Day and National Kidney Month, Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals To Release Fourth Quarter And Full Year 2018 Financial Results On March 19, 2019

Aurinia Pharmaceuticals To Release Fourth Quarter And Full Year 2018 Financial Results On March 19, 2019

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (the " Company") today announced that it will release its fourth quarter and full year 2018 financial results on Tuesday, March 19, 2019, after the market closes.

What's Keeping You Up?: Cramer's 'Mad Money' Recap (Wednesday 2/27/19)

What's Keeping You Up?: Cramer's 'Mad Money' Recap (Wednesday 2/27/19)

Jim Cramer says if you focus on what's going right, you'll sleep better and do a lot better with your money, too.

Waste Management, Weight Watchers, Centene: 'Mad Money' Lightning Round

Waste Management, Weight Watchers, Centene: 'Mad Money' Lightning Round

Jim Cramer weighs in on Waste Management, Weight Watchers, Centene, Aurinia Pharmaceuticals, Activision Blizzard, AbbVie, Cronos Group and more.

Aurinia Closes At-The-Market Facility

Aurinia Closes At-The-Market Facility

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (the " Company") today announced that, further to its Open Market Sale Agreement with Jefferies LLC previously disclosed on November 30, 2018, in relation to at-the-market ("ATM") offerings of common...

China and Biotech Stocks Are Running Hot

China and Biotech Stocks Are Running Hot

If you are an index trader it is a tough call, but for stock-pickers it remains a very good trading market.

Aurinia Receives Notice Of Allowance From The US Patent And Trademark Office For Claims Directed To Its Novel Voclosporin Dosing Protocol For Lupus Nephritis

Aurinia Receives Notice Of Allowance From The US Patent And Trademark Office For Claims Directed To Its Novel Voclosporin Dosing Protocol For Lupus Nephritis

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH/ TSX:AUP) (the "Company" or "Aurinia"), a clinical stage biopharmaceutical company focused on the global immunology market, today announced that it has received a Notice of Allowance from the United States Patent...

Aurinia To Present At The 8th Annual SVB Leerink Global Healthcare Conference New York City

Aurinia To Present At The 8th Annual SVB Leerink Global Healthcare Conference New York City

Aurinia Pharmaceuticals Inc., (NASDAQ:AUPH)(TSX:AUP) today announced its Chairman and Chief Executive Officer, Richard M.

Trading Notes for Select Stocks

Trading Notes for Select Stocks

Here's my take on a list of stocks I've been watching.

The Action in Select Small Caps Is Encouraging

The Action in Select Small Caps Is Encouraging

It's tough to do much while we await major news events.

There Are a Number of Justifications For Friday's Market Strength

There Are a Number of Justifications For Friday's Market Strength

Regardless of what is moving the markets, it is a good example of how you have to focus on price action above all else.

December 20th Options Now Available For Aurinia Pharmaceuticals (AUPH)

December 20th Options Now Available For Aurinia Pharmaceuticals (AUPH)

Investors in Aurinia Pharmaceuticals Inc saw new options become available today, for the December 20th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 329 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

The Short Setup Is Starting to Trigger

The Short Setup Is Starting to Trigger

Before I short aggressively I want to see a shift in the price action.

Aurinia Announces Voclosporin Ophthalmic Solution Demonstrates Statistically Superior Efficacy Versus Restasis® In A Phase 2 Head-to-Head Study For The Treatment Of Dry Eye Syndrome

Aurinia Announces Voclosporin Ophthalmic Solution Demonstrates Statistically Superior Efficacy Versus Restasis® In A Phase 2 Head-to-Head Study For The Treatment Of Dry Eye Syndrome

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH/TSX:AUP), a clinical stage biopharmaceutical company focused on the global immunology market, today announced positive results for its exploratory Phase 2 head-to-head study evaluating the efficacy, safety and...

Aurinia To Hold Conference Call And Webcast To Discuss Results Of Phase 2 Head-to-Head Study Of Voclosporin Ophthalmic Solution Versus Restasis® For The Treatment Of Dry Eye Syndrome

Aurinia To Hold Conference Call And Webcast To Discuss Results Of Phase 2 Head-to-Head Study Of Voclosporin Ophthalmic Solution Versus Restasis® For The Treatment Of Dry Eye Syndrome

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH/TSX:AUP), a clinical stage biopharmaceutical company focused on the global immunology market, today announced it will report results before the opening of trading and hold a webcast and conference call to discuss...

My Rx for How to Buy Aurinia Pharmaceuticals on Its Breakout

My Rx for How to Buy Aurinia Pharmaceuticals on Its Breakout

The charts indicate that buyers of Aurinia have been more aggressive in recent weeks after a period of consolidation.

How Much Would You Pay?: Cramer's 'Mad Money' Recap (Tuesday 1/15/19)

How Much Would You Pay?: Cramer's 'Mad Money' Recap (Tuesday 1/15/19)

Jim Cramer says Netflix serves as a reminder to all investors exactly how powerful the subscriber business is.

IBM, Nike, Newmont Mining: 'Mad Money' Lightning Round

IBM, Nike, Newmont Mining: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at IBM, Nike, Newmont Mining, U.S. Silica Holdings, Aurinia Pharmaceuticals, CenturyLink, Exxon Mobil and more.

February 2019 Options Now Available For Aurinia Pharmaceuticals (AUPH)

February 2019 Options Now Available For Aurinia Pharmaceuticals (AUPH)

Investors in Aurinia Pharmaceuticals Inc saw new options become available today, for the February 2019 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AUPH options chain for the new February 2019 contracts and identified the following put contract of particular interest.

Aurinia To Present At The 37th Annual J.P. Morgan Healthcare Conference In San Francisco

Aurinia To Present At The 37th Annual J.P. Morgan Healthcare Conference In San Francisco

Aurinia Pharmaceuticals Inc., (NASDAQ:AUPH)(TSX:AUP) today announced its Chairman and Chief Executive Officer, Richard M.

Aurinia Pharmaceuticals Breaks Below 200-Day Moving Average - Notable For AUPH

Aurinia Pharmaceuticals Breaks Below 200-Day Moving Average - Notable For AUPH

In trading on Tuesday, shares of Aurinia Pharmaceuticals Inc crossed below their 200 day moving average of $5.61, changing hands as low as $5.52 per share. Aurinia Pharmaceuticals Inc shares are currently trading down about 3.1% on the day.

Aurinia Establishes At-the-Market Facility

Aurinia Establishes At-the-Market Facility

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (" Aurinia" or the " Company") today announced that it has entered into an Open Market Sale Agreement (the " Sale Agreement") with Jefferies LLC (" Jefferies") pursuant to which the Company may from...

Aurinia To Participate In November Investor Conferences

Aurinia To Participate In November Investor Conferences

Aurinia Pharmaceuticals Inc., (NASDAQ:AUPH)(TSX:AUP) today announced its Chairman and CEO, Richard Glickman, will participate in two upcoming investor conferences.

Aurinia Reports Third Quarter Financial Results, Clinical Highlights And Corporate Development

Aurinia Reports Third Quarter Financial Results, Clinical Highlights And Corporate Development

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) ("Aurinia" or the "Company") has released its financial results for the third quarter ended September 30, 2018.

Aurinia Pharmaceuticals To Release Third Quarter Financial Results And General Business Updates On November 8, 2018

Aurinia Pharmaceuticals To Release Third Quarter Financial Results And General Business Updates On November 8, 2018

Aurinia Pharmaceuticals Inc., (NASDAQ:AUPH) (TSX:AUP) today announced that it will release its third quarter 2018 financial results on Thursday, November 8, 2018, after the market closes.

Notable Two Hundred Day Moving Average Cross - AUPH

Notable Two Hundred Day Moving Average Cross - AUPH

In trading on Friday, shares of Aurinia Pharmaceuticals Inc crossed below their 200 day moving average of $5.56, changing hands as low as $5.55 per share. Aurinia Pharmaceuticals Inc shares are currently trading down about 2.3% on the day.